Key Performance
More- Earnings Score: 94
- Momentum Score: 26
- True Yield: N/A
- Financial Health Score: 76
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP has filed a class action lawsuit against Insulet Corporation for securities violations, alleging the company made false and misleading statements regarding defective manufacturing controls and safety risks. The lawsuit covers the period from February 21, 2025 to May 26, 2026, with a deadline of August 31, 2026 for investors to participate.
08/07/2026, 9:45 AM • GlobeNewswire
Grabar Law Office has filed federal securities fraud class action investigations against four companies: Erasca for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet for defective manufacturing controls leading to voluntary product corrections; Power Solutions for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics for using undisclosed discount programs that artificially inflated sales and created excess inventory. Shareholders who purchased shares during specified periods are eligible to seek damages and corporate reforms.
08/07/2026, 9:32 AM • GlobeNewswire
Law Offices of Howard G. Smith announced class action lawsuits against three publicly-traded companies for securities fraud. Insulet Corporation faces allegations of defective manufacturing controls, Microvast Holdings is accused of overstating margin targets and expansion timelines, and Hub Group is charged with material misstatements in financial reporting. Investors have until late August and September 2026 to file lead plaintiff motions.
08/04/2026, 2:15 PM • GlobeNewswire
Insulet Corporation (PODD) faces a class action securities fraud lawsuit alleging the company failed to disclose defective manufacturing controls that led to two voluntary medical device corrections in March and May 2026. The disclosures caused significant stock price declines of 6.9% and 5.1% respectively. Investors who purchased shares between February 21, 2025 and May 26, 2026 have until August 31, 2026 to file a lead plaintiff motion.
08/04/2026, 1:40 PM • GlobeNewswire
Grabar Law Office has launched investigations into potential securities fraud and fiduciary duty breaches at four major companies: Erasca (ERAS) for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet (PODD) for defective manufacturing controls leading to voluntary product corrections; Power Solutions International (PSIX) for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics (PRCT) for using undisclosed discount programs that artificially inflated sales figures and created excess inventory.
08/04/2026, 11:49 AM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks for its products.
08/01/2026, 6:34 AM • GlobeNewswire
The Gross Law Firm has issued notices regarding multiple securities class action lawsuits. Insulet Corporation faces allegations of defective manufacturing controls and misleading statements regarding product safety, with a lead plaintiff deadline of August 31, 2026. Similar class action notices were issued for PROCEPT BioRobotics Corporation and Helen of Troy Limited, with deadlines in September 2026.
07/31/2026, 10:23 AM • GlobeNewswire
Grabar Law Office has initiated multiple shareholder investigations into alleged securities fraud and fiduciary duty breaches at EquipmentShare.com, Insulet Corporation, New Era Energy & Digital, and Planet Fitness. The investigations allege undisclosed related-party transactions, defective manufacturing controls, misleading statements about business progress, and false marketing claims that caused shareholders to purchase securities at artificially inflated prices.
07/31/2026, 9:24 AM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of an important August 31, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations.
07/29/2026, 10:53 PM • GlobeNewswire
Grabar Law Office announced investigations into multiple publicly traded companies on behalf of shareholders, alleging breaches of fiduciary duties and securities law violations. The investigations cover Erasca (misleading statements about ERAS-0015 drug candidate and patent infringement), Insulet (defective manufacturing controls leading to product recalls), New Era Energy & Digital (overstated project progress and fraudulent oil-and-gas schemes), Power Solutions International (overstated sales demand and understated manufacturing costs), Hub Group, Planet Fitness, Primoris Services, EquipmentShare.com, GPGI, Photronics, and Via Transportation. Shareholders who meet specific holding criteria may seek damages and corporate governance reforms at no cost.
07/29/2026, 8:43 AM • GlobeNewswire
Kirby McInerney LLP has filed a securities fraud class action lawsuit against Insulet Corporation on behalf of investors who purchased securities between February 21, 2025 and May 26, 2026. The lawsuit alleges that Insulet failed to disclose defective manufacturing controls and safety risks. Two significant product corrections were announced in March and May 2026, resulting in substantial stock price declines of approximately 7% and 5% respectively. The deadline to request lead plaintiff appointment is August 31, 2026.
07/27/2026, 8:40 PM • GlobeNewswire
Rosen Law Firm announces a securities class action lawsuit against Insulet Corporation, alleging the company made false statements regarding defective manufacturing controls and procedures that created safety risks. Investors who purchased PODD securities between February 21, 2025 and May 26, 2026 may be eligible for compensation. The lead plaintiff deadline is August 31, 2026.
07/26/2026, 8:33 AM • GlobeNewswire
Law Offices of Howard G. Smith has filed securities fraud class action lawsuits against four publicly-traded companies: Futu Holdings (FUTU) for regulatory non-compliance in China, Hub Group (HUBG) for financial statement misstatements, Insulet Corporation (PODD) for defective manufacturing controls, and Photronics Inc. (PLAB) for misleading statements about chip design pipeline bottlenecks. Investors have until late August/early September 2026 to file lead plaintiff motions.
07/21/2026, 1:41 PM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks, resulting in investor damages.
07/20/2026, 2:54 PM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Planet Fitness, Insulet Corporation, and Photronics, Inc. on behalf of investors who purchased securities during specified periods. The lawsuits allege that these companies made materially false and misleading statements regarding business metrics and financial guidance. Investors have until September 14, 2026 to move the court to serve as lead plaintiff.
07/20/2026, 2:46 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 08/21/2026
Company Profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.